Both of you are incorrect.
Biotron began the CTAP process.
The advice came back from the FDA on designing a phase 2 trial which we are expecting results on shortly. Funding was an issue at the time.
Since early 2022 the FDA have tightened their guidelines around CTAP as the pandemic lessened. This was stated by Miller.
Covid is still a real problem.
Alot to be excited about with both HIV and Covid phase 2 trials due shortly.
Good luck all.
Both of you are incorrect.Biotron began the CTAP process.The...
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $48.72M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.4¢ | 5.2¢ | $2.393K | 44.94K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 19600 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 188178 | 2 |
View Market Depth
| Last trade - 15.15pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
5.4¢ |
Change
0.000 ( 3.85 %) |
||||
| Open | High | Low | Volume | ||
| 5.4¢ | 5.4¢ | 5.2¢ | 120722 | ||
| Last updated 15.15pm 03/05/2024 ? | |||||
| BIT (ASX) Chart |